both planned and spontaneous. One prominent example, arising from the ever-growing recognition of the need for greater reproducibility during clinical translation146, is an explicit requirement for independent
monitor, designed to be implanted in combination with a vascular access port, which will interface with the Veris Cancer Care Platform. The implantable monitor will further enhance the clinical and commercial value of the platform by providing remote physiologic data independ...
1 J Res Med Sci. 2012 Apr;17(4):407-11. A novel treatment strategy for eyebrow transplantation in an ectodermal dysplasia patient. Nilforoushzadeh MA(1), Adibi N, Mirbagher L. 1)Associate professor, Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran...
1 J Res Med Sci. 2012 Apr;17(4):407-11. A novel treatment strategy for eyebrow transplantation in an ectodermal dysplasia patient. Nilforoushzadeh MA(1), Adibi N, Mirbagher L. 1)Associate professor, Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran...
1 J Res Med Sci. 2012 Apr;17(4):407-11. A novel treatment strategy for eyebrow transplantation in an ectodermal dysplasia patient. Nilforoushzadeh MA(1), Adibi N, Mirbagher L. 1)Associate professor, Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran...
1 J Res Med Sci. 2012 Apr;17(4):407-11. A novel treatment strategy for eyebrow transplantation in an ectodermal dysplasia patient. Nilforoushzadeh MA(1), Adibi N, Mirbagher L. 1)Associate professor, Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran...
1 J Res Med Sci. 2012 Apr;17(4):407-11. A novel treatment strategy for eyebrow transplantation in an ectodermal dysplasia patient. Nilforoushzadeh MA(1), Adibi N, Mirbagher L. 1)Associate professor, Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran...
1 J Res Med Sci. 2012 Apr;17(4):407-11. A novel treatment strategy for eyebrow transplantation in an ectodermal dysplasia patient. Nilforoushzadeh MA(1), Adibi N, Mirbagher L. 1)Associate professor, Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran...
•eTravel–thefirstsuccessfulSOAimplementationineTravelamongallFederalagencies(average8,000transactions/month)•FederalAcquisition(twocontracts)–thefirstNBSSOAimplementation(average20,000transactions/month)•NIHannualgrantcommitmentsandobligations–(average$20-25billionUS/year)•PatientTravel–Expensereimbursement...